APA (7th ed.) Citation

L, H., M, H., B, S., M, J., BS, H., DJM, B., . . . T, R. (2026). The Vasopressin Biomarker Copeptin Is Linked to Systemic Inflammation and Refines Prognostication in Decompensated Cirrhosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 24(1), 131. https://doi.org/10.1016/j.cgh.2025.04.030

Chicago Style (17th ed.) Citation

L, Hartl, et al. "The Vasopressin Biomarker Copeptin Is Linked to Systemic Inflammation and Refines Prognostication in Decompensated Cirrhosis." Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 24, no. 1 (2026): 131. https://doi.org/10.1016/j.cgh.2025.04.030.

MLA (9th ed.) Citation

L, Hartl, et al. "The Vasopressin Biomarker Copeptin Is Linked to Systemic Inflammation and Refines Prognostication in Decompensated Cirrhosis." Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, vol. 24, no. 1, 2026, p. 131, https://doi.org/10.1016/j.cgh.2025.04.030.